Implantica AG (FRA:8IM1) Ending Cash Position: €0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8IM1 Implantica AG FRA:8IM1
34 GF Score
Price €5.36
View Full Analysis

What is Implantica AG Ending Cash Position?

Implantica AG FRA:8IM1 -4.46% 34 Ending Cash Position is €0.00 Mil as of . 20. GuruFocus rates FRA:8IM1 with a GF Score™ of 34/100.

Implantica AG's Ending Cash Position for the quarter that ended in . 20 was €0.00 Mil.

Implantica AG Ending Cash Position Related Terms

Implantica AG Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Implantica AG's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Implantica AG Ending Cash Position Chart

Implantica AG Annual Data
Trend
Ending Cash Position

Implantica AG Semi-Annual Data
Ending Cash Position
FRA:8IM1
34GF Score
Implantica AG FRA:8IM1
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Implantica AG Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Implantica AG's Ending Cash Position for the fiscal year that ended in . 20 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=+
=0.00

Implantica AG's Ending Cash Position for the quarter that ended in . 20 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=+
=0.00

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €0.00 Mil mean?
Implantica AG (FRA:8IM1) has a Ending Cash Position of €0.00 Mil as of . 20. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Implantica AG and its competitors.
Is Implantica AG's Ending Cash Position too high?
Implantica AG's current Ending Cash Position is €0.00 Mil. Overall, Implantica AG has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Implantica AG's Ending Cash Position compare to ?
Implantica AG's Ending Cash Position of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Implantica AG and its competitors. Implantica AG's current Ending Cash Position is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implantica AG stock overvalued right now?
Implantica AG (FRA:8IM1) has a current Ending Cash Position of €0.00 Mil. The current Ending Cash Position is €0.00 Mil. Implantica AG's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Implantica AG (FRA:8IM1), the current Ending Cash Position is €0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Implantica AG Business Description

Comparable Companies
Other Exchanges IMP A SDB:Sweden
Address Aeulestrasse 15, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected product pipeline based partly on its two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body, and communicate with the caregiver at a distance, and a wireless energising platform designed to power remote-controlled implants wirelessly through intact skin.
34GF Score

Get the complete analysis for FRA:8IM1

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.36
Price